Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Sofgen Pharma S.A/ 15-12G

SEC Filing · 15-12G

Sofgen Pharma S.A

PROCFOTCEQUITYCurrent

SEC Filing

Filed Mar 16, 2026Accepted Mar 16, 2026, 4:34 PM EDTCIK 1863362Accession 0001213900-26-028339
View company →Permanent SEC source ↗
Share

Company context

Current securities

PRCWFOTC · WARRANT · CurrentPROCFOTC · EQUITY · Current
Historical securities (2)
PROCNASDAQ · EQUITY · Historical · closed Feb 3, 2025PROCWNASDAQ · WARRANT · Historical · closed Jan 30, 2025

Recent company filings

  1. 3 filingMar 19, 2026
  2. 3 filingMar 18, 2026
  3. 3 filingMar 18, 2026
  4. 20-F filingMar 16, 2026
  5. 6-K filingDec 5, 2025

As-filed source

Primary evidence
As filedOpen full document ↗